4DMedical’s Andreas Fouras is ready to exhale after a dealmaking blitz
The $2 billion medical imaging company and ASX market darling transformed itself in the space of 48 hours this week, with a geography expanding acquisition and a major product release.
“People ask me all the time where I live. In airport lounges, honestly.”
4DMedical founder and CEO Andreas Fouras has had a big couple of days. On Monday, he announced his medical imaging software company had expanded to Europe “over the weekend”.
Then, just 24 hours later, he unveiled the launch of a new clinical evidence program with the potential to grow the company’s target opportunity five-fold.
But the latest announcements in a relentless drumbeat of contract wins and regulatory clearances, which have sent the stock soaring (it’s up more than 1000% over the past year) may well mark the end of the streak. For a while, at least.
